Your Compass for Pharma Success

INVESTIGATION REPORT FOR HARDNESS FAILURE DURING IN-PROCESS CHECK AT COMPRESSION STAGE IN AMLODIPINE 10 MG TABLETS

INVESTIGATION REPORT FOR HARDNESS FAILURE DURING IN-PROCESS CHECK AT COMPRESSION STAGE IN AMLODIPINE 10 MG TABLETS
INVESTIGATION REPORT FOR HARDNESS FAILURE DURING IN-PROCESS CHECK AT COMPRESSION STAGE IN AMLODIPINE 10 MG TABLETS

INVESTIGATION REPORT

Hardness Failure During In-Process Check at Compression Stage

1. Objective

To investigate and identify the root cause for the failure in tablet hardness observed during the in-process check at the compression stage for Amlodipine Tablet 10 mg, Batch No. PGH/T/25-002 on 21/07/25, and to recommend suitable corrective and preventive actions (CAPA) to prevent recurrence.

Key Parameter of Below Page:

Hardness Failure During In-Process Check at Compression Stage

Find below pages for complete report

INVESTIGATION REPORT FOR HARDNESS FAILURE DURING IN-PROCESS CHECK AT COMPRESSION STAGE IN AMLODIPINE 10 MG TABLETS

Click the link to download word file copy of this document:
https://pharmaguidehub.com/product/investigation-report-for-hardness-failure-during-in-process-check-at-compression-stage-in-amlodipine-10-mg-tablets/

Key Parameter of Below Page:

Hardness Failure During In-Process Check at Compression Stage

Find below pages for complete report

INVESTIGATION REPORT FOR HARDNESS FAILURE DURING IN-PROCESS CHECK AT COMPRESSION STAGE IN AMLODIPINE 10 MG TABLETS

Key Parameter of Below Page:

Hardness Failure During In-Process Check at Compression Stage

Find below pages for complete report

INVESTIGATION REPORT FOR HARDNESS FAILURE DURING IN-PROCESS CHECK AT COMPRESSION STAGE IN AMLODIPINE 10 MG TABLETS

Key Parameter of Below Page:

Hardness Failure During In-Process Check at Compression Stage

Find below pages for complete report

INVESTIGATION REPORT FOR HARDNESS FAILURE DURING IN-PROCESS CHECK AT COMPRESSION STAGE IN AMLODIPINE 10 MG TABLETS

Key Parameter of Below Page:

Hardness Failure During In-Process Check at Compression Stage

Find below pages for complete report

INVESTIGATION REPORT FOR HARDNESS FAILURE DURING IN-PROCESS CHECK AT COMPRESSION STAGE IN AMLODIPINE 10 MG TABLETS

Key Parameter of Below Page:

Hardness Failure During In-Process Check at Compression Stage

Find below pages for complete report

INVESTIGATION REPORT FOR HARDNESS FAILURE DURING IN-PROCESS CHECK AT COMPRESSION STAGE IN AMLODIPINE 10 MG TABLETS

Click the link to download word file copy of this document:
https://pharmaguidehub.com/product/investigation-report-for-hardness-failure-during-in-process-check-at-compression-stage-in-amlodipine-10-mg-tablets/

YOU CAN ALSO READ:

INVESTIGATION REPORT FOR ASSAY FAILURE OBSERVATION DURING TESTING OF AMLODIPINE 10 MG TABLETS

INVESTIGATION REPORT FOR THE OBSERVATION OF BLACK PARTICLE IN COMPRESSED TABLET AFTER COMPRESSION

INVESTIGATION REPORT FOR WATER LEAKAGE FROM COMPRESSION ROOF

INVESTIGATION REPORT FOR LEAK TEST FAILURE OF BLISTER PACK

INVESTIGATION REPORT FOR WRONG BATCH CODING OBSERVED ON MONOCARTON DURING SECONDARY PACKING

INVESTIGATION REPORT FOR THE OBSERVATION OF A LIVE LIZARD IN THE TABLET QUARANTINE AREA

6M-Based Investigation on Tablet Chipping at Compression Stage

INVESTIGATION REPORT FOR RAW MATERIAL SPILLAGE DURING DISPENSING

INVESTIGATION REPORT FOR OBSERVATION OF FLY IN MANUFACTURING CORRIDOR

INVESTIGATION REPORT FOR LOWER YIELD AT COMPRESSION STAGE

STANDARD OPERATING PROCEDURE FOR THE HANDLING OF DEVIATIONS AND INCIDENTS

CORRECTIVE AND PREVENTIVE ACTION (CAPA)   IN PHARMACEUTICAL

Share this article
Shareable URL
Prev Post

INVESTIGATION REPORT FOR ASSAY FAILURE OBSERVATION DURING TESTING OF AMLODIPINE 10 MG TABLETS

Next Post

PHASE 1 INVESTIGATION REPORT FOR ASSAY FAILURE IN AMLODIPINE TABLETS 10 MG

Comments 1
  1. It’s great to see such a thorough investigation into the hardness failure. I’d be curious to know if the corrective actions being recommended are focused on adjustments in the formulation or the compression equipment settings to prevent this in future batches.

Leave a Reply

Your email address will not be published. Required fields are marked *

Read next

Discover more from PharmaGuideHub

Subscribe now to keep reading and get access to the full archive.

Continue reading